Abstract
Franquet T, Muller NL, Lee KS, Gimenez A, Flint JD he term “hematopoietic stem cell [HSC] transplantation” has replaced the previously used term “bone marrow transplantation” to reflect the broader range of donor stem cell sources that are now available [1]. HSC transplantation is being used with increasing frequency for treatment of leukemia, aplastic anemia, myeloma, and some forms of lymphoma and solid tumors. Although HSC transplantation is a well-established procedure, pulmonary infection and noninfectious
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
